Robert Driscoll
#229 out of 1697 analysts
Wedbush
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
46.78%
Gain -16.58%
Monthly
0.65%
Yearly
8.04%
Drawdown
66.09%
$177,739.39
Equity
Holdings
$177,739.39
Cash
$0
Investment
$174,837.45
$77,739.39
Profit -$35,321.76
Realized
$74,837.45
Unrealized
$2,901.94
Dividends
$0
$0
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-16.58%
Profit
-$35,321.76
Win %
75%
This Week
Compared To Last Week
Gain
7.16%
Profit
$11,874.94
Win %
78%
This Month
Compared to last month
Gain
7.16%
Profit
$11,874.94
Win %
78%
This Year
Compared to last year
Gain
59.81%
Profit
$66,519.87
Win %
71%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 994 | Longs Won 454/986 46% | Profit Factor 1.26 |
| Profitability | Shorts Won 7/8 87% | Standard Deviation $1,979.2 |
| Average Win $815.63 | Best Trade (Jul 08) $27,158.09 | Sharpe Ratio -193.98 |
| Average Loss -$559.6 | Worst Trade (Jun 07) -$18,381.78 | Z-Score -9.88 (100%) |
| Commissions $0 | Avg. Trade Length 2m 1w 5d | Expectancy $78.21 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | 0.02% | 0.16% | 0.75% | 2.72% | 8.07% | 20.7% | 47.54% |
| Consecutive Losing Trades | 318 | 286 | 254 | 222 | 191 | 159 | 127 | 95 | 64 | 32 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
 GLUE Monte Rosa Therapeutics, Inc. | 2,219.71 | $34,210.79 | $35,249.01 | - | $1,038.22 | 3.03% | +1.082% |
 IDYA Ideaya Biosciences Inc. | 992.93 | $35,249.01 | $36,743.37 | - | $1,494.36 | 4.24% | +2.111% |
 RCUS Arcus Biosciences Inc. | 1,231.19 | $34,879.65 | $35,249.01 | - | $369.36 | 1.06% | +1.059% |
 REPL Replimune Group Inc. | 2,922.8 | $35,249.01 | $35,249.01 | - | - | - | -6.221% |
 RVMD Revolution Medicines Inc. | 171.82 | $35,249.01 | $35,249.01 | - | - | - | +3.711% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
